Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ¿¡¼­ °­Áö ÀÓ»ó°æ°ú¿¡ ´ëÇÑ C-Reactive ProteinÀÇ ¿ªÇÒ The role of C-reactive protein on long-term clinical outcomes in parients with acute myocardial infarction

´ëÇѳ»°úÇÐȸÁö 2001³â 61±Ç 6È£ p.606 ~ 615
¼Ò¼Ó »ó¼¼Á¤º¸
È«¿µÁØ/Young Joon Hong Á¤¸íÈ£/¹ÚÇü¿í/À̽ÂÇö/¹Ú¿Á¿µ/Á¤¿ì°ï/ÀÌ»ó·Ï/¿°ÁÖÇù/±è¿ø/±èÁÖÇÑ/·ùÁ¦¿µ/¾È¿µ±Ù/Á¶Á¤°ü/¼­¼øÆÈ/¾Èº´Èñ/¹ÚÁ¾Ãá/±è»óÇü/°­Á¤Ã¤/Myung Ho Jeong/Hyung Wook Park/Seung Hyung Lee/Ok Young Park/Woo Kon Jeong/Sang Rok Lee/Ju Hyup Yum/Weon Kim/Ju Han Kim/Jay Young Rhew/You

Abstract

¸ñÀû: ±Þ¼º ½É±Ù °æ»öÁõ ȯÀÚ¿¡¼­ ±¸Ã¼Àû ¹× ÀÏÂ÷Àû °ü»óµ¿¸Æ ÁßÀç¼úÀ» ½ÃÇàÇÑ È¯ÀÚ ±ºÀ» ´ë»óÀ¸·Î ³»¿ø½Ã C-Reactive Protein (CRP) ¼öÄ¡¿¡ µû¸¥ ÀÓ»óÀû, °ü»óµ¿¸Æ Á¶¿µ¼ú»ó Ư¡, °ü»óµ¿¸Æ ÁßÀç¼úÀÇ ¼º°ø·ü, 1³â°£ Àå±â »ýÁ¸À², µ¶¸³ÀûÀÎ ¿¹ÈÄ ÀÎÀÚ µî¿¡
´ëÇØ
°üÂûÇÏ¿´´Ù. ´ë»ó¹×¹æ¹ý: 1997³â 1¿ùºÎÅÍ 1999³â 12¿ù±îÁö Àü³²´ëÇб³ º´¿ø ½ÉÀå¼¾ÅÍ¿¡ ÀÔ¿øÇÏ¿© ±¸Á¦Àû ¹× ÀÏÂ÷Àû °ü»óµ¿¸Æ ÁßÀç¼úÀ» ½ÃÇà¹Þ¾Ò´ø ±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ 208¿¹¸¦ ´ë»óÀ¸·Î ³»¿ø½Ã CRP°¡ 1 §·/dL ¹Ì¸¸À̾ú´ø ±ºÀ» ¥°±º (59.9¡¾9.3¼¼, ³²: 64,
¿©:
22)À¸·Î, CRP°¡ 1 §·/dLÀÌ»óÀ̾ú´ø ±ºÀ» ¥±±º (59.1¡¾10.4¼¼, ³²: 102, ¿©: 20)À¸·Î ºÐ·ùÇÏ¿´°í ¾ç±º »çÀÌ¿¡ ÀÓ»óÀû ¹× °ü»óµ¿¸Æ Á¶¿µ¼ú Ư¼º ¹× ¾ç±º¿¡¼­ 1°³¿ù, 6°³¿ù, 12°³¿ù »ýÁ¸À²À» °üÂûÇÏ¿´´Ù. °á°ú: 1) °ü»óµ¿¸Æ Áúȯ½Ã À§ÇèÀÎÀÚ´Â ¾ç±º°£¿¡ Â÷ÀÌ°¡
¾ø¾úÀ¸¸ç (p=NS), ¥±±º¿¡¼­ °ü»óµ¿¸Æ ÁßÀç¼ú½Ã Ç÷¾ÐÀÌ 90/60 mmHg ÀÌÇÏÀÎ ½ÉÀμº ¼îÅ©°¡ ¸¹¾Ò´Ù (¥°±º; 3/86¸í, 3.5% vs. ¥±±º; 15/122¸í, 12.3%, p=0.026). 2) °æ»ö°ü·Ã Ç÷°üÀÇ ºÐÆ÷, American College of Cardiology/American Heart Association ÇüÅÂ, º´º¯
Ç÷°üÀÇ
¼ö,
Ç÷Àü ³»Àç º´º¯, Thrombolysis In Myocardial Infarction flow µî °ü»óµ¿¸ÆÁ¶¿µ¼ú»ó ¾ç±º°£¿¡ À¯ÀÇÇÑ Â÷ÀÌ´Â ¾ø¾ú´Ù (p=NS). 3) Pain to admission timeÀº ¥°±º 195¡¾120ºÐ, ¥±±º 200¡¾117ºÐ, Pain to balloon timeÀº ¥°±º 278¡¾99ºÐ, ¥±±º 282¡¾101ºÐÀ¸·Î¼­ °¢°¢
¾ç±º
»çÀÌ¿¡ Â÷ÀÌ°¡ ¾ø¾ú°í (°¢°¢ p=0.860, p=0.843), °ü»óµ¿¸Æ ÁßÀç¼úÀÇ ÀÏÂ÷ ¼º°ø·üµµ ¥°±º 94.2%, ¥±±º 95.1%·Î¼­ ¾ç±º »çÀÌ¿¡ Â÷ÀÌ°¡ ¾ø¾ú´Ù (p=0.776). 4) ¾ç±º ¸ðµÎ¿¡¼­ TIMI flow´Â ½Ã¼ú Àü¿¡ ºñÇØ Áõ°¡µÇ¾ú°í (¥°±º 1.52¡¾1.13, 2.77¡¾0.55 vs. ¥±±º 1.55¡¾1.11,
2.76¡¾0.53, p£¼0.001) ¾ç±º°£¿¡ Â÷ÀÌ´Â ¾ø¾úÀ¸¸ç (p=0.863), ±¸Ç÷·üµµ Áõ°¡µÇ¾ú°í (¥°±º 49.4¡¾10.5%, 52.0¡¾9.0% vs. ¥±±º 50.1¡¾11.2%, 52.7¡¾9.7%, p£¼0.001) ¾ç±º°£¿¡ Â÷ÀÌ´Â ¾ø¾ú´Ù (p=0.553). 5) Àç¿ø ±â°£ Áß ÁÖ¿ä ½ÉÀå»ç·Î ½É±Ù°æ»ö¿¡ À־´Â ¾ç±º°£¿¡
Â÷ÀÌ´Â
¾ø¾úÀ¸³ª Ç¥Àû Ç÷°ü revascularization¿¡ À־ ¥±±º¿¡¼­ À¯ÀÇÇÏ°Ô ³ô¾ÒÀ¸¸ç (¥°±º 4.7% vs. ¥±±º 8.2%, p=0.043), Àç¿ø ±â°£ Áß »ç¸Á¿¡ À־µµ ¥±±º¿¡¼­ À¯ÀÇÇÏ°Ô ¸¹¾Ò´Ù (¥°±º 2.3% vs. ¥±±º 7.4%, p=0.040). 1³â°£ ÃßÀû °üÂû Áß ÀçÇùÂø ¹× Ç¥Àû Ç÷°ü
revascularization¿¡ À־ ¥±±º¿¡¼­ À¯ÀÇÇÏ°Ô ³ô¾Ò´Ù (°¢°¢ ¥°±º 15.1%, 11.6% vs. ¥±±º 28.7%, 23.8%, p=0.009, 0.017). 6) °ü»óµ¿¸Æ ÁßÀç¼ú ÈÄ 1°³¿ù »ýÁ¸À²Àº ¥°±º 97.7%, ¥±±º 91.8%, 6°³¿ù »ýÁ¸À²Àº ¥°±º 97.7%, ¥±±º 91.0% , 12°³¿ù »ýÁ¸À²Àº ¥°±º 96.5%,
¥±±º
86.9%·Î¼­, ¥±±º¿¡¼­ ¥°±º¿¡ ºñÇØ 1°³¿ù, 6°³¿ù ¹× 12°³¿ù »ýÁ¸À²ÀÌ À¯ÀÇÇÏ°Ô ³·¾Ò´Ù (°¢°¢ p=0.043, 0.040, 0.018). 7) ³»¿ø½Ã ½ÉÀμº ¼îÅ©°¡ µ¿¹ÝµÈ °æ¿ì, ³»¿ø½Ã CRP ³óµµ°¡ 1 §·/dL ÀÌ»óÀ̾ú´ø °æ¿ì, °ü»óµ¿¸Æ ÁßÀç¼ú ÀÌÈÄ ÁÂ½É½Ç ±¸Ç÷·üÀÌ 40% ¹Ì¸¸À̾ú´ø
°æ¿ì°¡
ÁÖ¿äÇÑ µ¶¸³ÀûÀÎ ¿¹ÈÄ ÀÎÀÚ¿´´Ù (°¢°¢ p£¼0.001, 0.001, 0.043). °á·Ð: ±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ¿¡¼­ ³»¿ø½Ã CRP ³óµµ´Â ÁÖ¿äÇÑ µ¶¸³ÀûÀÎ ¿¹ÈÄ ÀÎÀÚ¿´À¸¸ç, CRP ³óµµ°¡ ³ô¾Ò´ø ȯÀÚ¿¡¼­ ³»¿ø½Ã ½ÉÀμº ¼îÅ©°¡ ¸¹ÀÌ µ¿¹ÝµÇ¾úÀ¸¸ç, ÃßÀû°üÂû Áß ½ÉÀå »ç¸Á·üÀÌ
³ô¾Ò´Ù.

Background: The inflammartion is an important feature of atherosclerotic lesions, and high level of C-reactive protein (CRP) is known to be associated with increased coronary events and poor prognosis in acute myocardial infarction (AMI).
We
examined the clinical and angiographic outcomes, success rate of the percutaneous coronary intervention (PCI), and long-term survival rate after PCI according to the level of CRP on admission. Methods: Two hundred and eight patients with
AMI
who
underwent primary of rescue PCI between 1997 and 1999 at Chonnam National University Hospital were divided into two group:Group¥°(n=86, 59.9¡¾9.3 years, male 74.4%) with normal CRP (£¼1.0 §·/dL, mean value=0.43¡¾0.14 §·/dL) on admission and Group
¥±(n=122, 59.1¡¾10.4 years, male 83.6%) with elevated CRP (¡Ã1.0 §·/dL, mean value=3.50¡¾0.93 §·/dL) on admission. Results: There were no significant differences in baseline characteristics between two groups. The incidence of cardiogenic
shock
was higher in Group ¥± than in Group ¥° (Group ¥°; 3/86, 3.5% vs Group ¥± ; 15/122, 12.3%, p=0.026). The coronary angiographic findings were not different between two groups. The ejection fraction and Thrombolysis In Myocardial Infarction flow
were
improved after PCI in both groups (Group ¥°; 49.4¡¾10.5 to 52.0¡¾9.0%, 1.52¡¾1.13 to 2.77¡¾0.55, p£¼0.001 vs Group ¥±;50.1¡¾11.2 to 52.7¡¾9.7, 1.55¡¾1.11 to 2.76¡¾0.53, p£¼0.001). Primary success rate of PCI was 94.2% (82/86) in Group ¥°and 95.1%
(116/122) in Group ¥± (p=0.776). The survival rates of Group ¥° was 97.7%, 97.7% and 96.5%, and those of Group ¥± was 91.8%, 91.0% and 86.9% at 1, 6 and 12 months, respectively (p=0.043 at 1 month, p=0.040 at 6 months, p=0.018 at 12 months).
Conclusion: Higher incidence of cardiogenic shock and worse long-term survival after PCI are observed in AMI patients with elevated CRP.

Å°¿öµå

Acute Myocardial Infarction; Percutaneous Coronary Intervention; C-reactive Protein;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS